v3.20.2
Consolidated Balance Sheets - USD ($)
Jun. 30, 2020
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Current assets:        
Cash $ 712 $ 1,838 $ 3,378 $ 3,111
Total assets 712 1,838 3,378 3,111
Current liabilities:        
Accounts payable and accrued liabilities 1,131,676 1,128,081 1,014,268 1,038,073
Promissory notes payable due to related parties 3,031,966 3,031,966 2,891,966 2,891,966
Promissory notes payable to unrelated parties 2,254,353 2,254,353 2,394,353 2,394,353
Interest payable 5,630,831 5,364,997 4,836,127 4,307,256
Lines of credit from related parties 20,472,110 19,310,707 17,261,650 15,347,842
Total liabilities 32,520,936 31,090,104 28,398,364 25,979,490
Stockholders' Deficit        
Preferred stock Authorized: 500,000,000 (December 31, 2019 - 500,000,000) shares of preferred stock with a par value of $0.001 per share Shares issued and outstanding: Nil (December 31, 2019 - Nil) shares of preferred stock were issued and outstanding
Common stock Authorized: Authorized: 10,000,000,000 (December 31, 2019 - 10,000,000,000) shares of common stock with a par value of $0.001 per share Shares issued and outstanding: 270,777,909 shares of common stock (December 31, 2019 - 268,777,909 shares of common stock) 270,777 268,777 242,777 242,777
Additional paid-in capital 56,848,086 56,298,702 50,012,445 48,308,919
Accumulated deficit (89,639,087) (87,655,745) (78,650,208) (74,528,075)
Stockholders' deficit (32,520,224) (31,088,266) (28,394,986) (25,976,379)
Total liabilities and stockholders' deficit $ 712 $ 1,838 $ 3,378 $ 3,111